BioNexus Gene Lab Corp (BGLC) Stock Price

1.28 ▼ -0.27 (-17.42%)
Open: 1.275 Vol: 0 Day's range: 1.275 - 1.295 Aug 26, 09:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BGLC Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.53▼ 1.53▼ 1.48▼ 1.52▼ 1.48▼
MA10 1.55▼ 1.56▼ 1.58▼ 1.55▼ 1.65▼
MA20 1.66▼ 1.81▼ 1.89▼ 1.51▼ 1.92▼
MA50 2.10▼ 2.07▼ 2.09▼ 1.76▼ 3.03▼
MA100 2.08▼ 2.21▼ 2.22▼ 1.96▼ 3.37▼
MA200 2.37▼ 2.87▼ 3.18▼ 2.67▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.030▼ -0.048▼ 0.002▲ 0.002▲
RSI 29.130▼ 31.109▼ 31.880▼ 31.838▼ 33.093▼
STOCH 57.573     41.098     24.529     12.293▼ 22.392    
WILL %R -98.864▼ -99.379▼ -99.379▼ -99.174▼ -87.117▼
CCI -206.103▼ -166.424▼ -152.072▼ -357.453▼ -102.524▼
Latest Filters Detected On BGLC
MA $BGLC Price Crossed Below MA(26) Set Alert
▼ GAP $BGLC Open Gap Down %5 Set Alert
▼ GAP $BGLC Open Gap Down %3 Set Alert
▼ GAP $BGLC Open Gap Down %2 Set Alert
▼ BREAK $BGLC Price Breaks 10 Days Low Set Alert
CDL $BGLC Doji Candlestick Pattern Detected Set Alert
BioNexus Gene Lab Corp News
BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit
Tuesday, July 28, 2026 02:00 AM
KUALA LUMPUR, Malaysia, July 28, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) ("BioNexus" or the "Company") today announced continued progress toward commercializing the VitaGuard™ ...
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development
Friday, May 29, 2026 06:00 AM
Sam Tan, Chief Executive Officer of BioNexus Gene Lab Corp. (Nasdaq: BGLC), speaking at the 2026 China–Malaysia Economic Cooperation Outlook Forum in Kuala Lumpur Sam Tan, Chief Executive Officer of ...
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and ...
Tuesday, December 02, 2025 05:06 AM
SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC” or the “Company”), an emerging provider of precision oncology diagnostics with expanding operations across Southeast ...
BGLC historical stock data
date open high low close volume
26/08/26 1.275 1.295 1.275 1.28 2,936
25/08/26 1.57 1.57 1.5194 1.55 483
21/08/26 1.70 1.70 1.58 1.59 1,032
20/08/26 1.61 1.61 1.58 1.5865 2,996
19/08/26 1.5734 1.655 1.57 1.57 8,711
18/08/26 1.62 1.6646 1.54 1.54 6,056
17/08/26 1.63 1.88 1.55 1.5911 96,728
14/08/26 1.64 1.64 1.57 1.57 2,135
13/08/26 1.60 1.64 1.60 1.64 2,300
12/08/26 1.59 1.59 1.52 1.55 2,838
Quote Details
52wk Low:1.07
52wk High:6.10
Vol:0
Avg Vol(3m):2M
1Y Chng:-70.71%
1M Chng:-23.81%
Add to Watch List
More Information
Index US Composite
Market Cap. 4.55M